As Medical Director for Personalized Medicine at Moffitt Cancer Center, Howard McLeod became frustrated at the lack of tools to help individualize treatments for cancer patients. “If no company is going to provide these for us, we’d better build them ourselves,” he decided.
So McLeod, PharmD. and Moffitt Personalized Medicine Strategist Neil T. Mason, Ph.D., created their own company, Interpares Biomedicine. With Moffitt’s Jamie Teer, Ph.D., an Assistant Member, and a seasoned biotech executive Kevin Krenitsky, M.D., they created their own set of tools to help doctors and patients sort through a number of seemingly equal immunotherapy options.